Literature DB >> 8033920

A family of selective immunodeficiency with normal immunoglobulins: possible autosomal dominant inheritance.

S Higuchi1, H Awata, H Nunoi, H Tsuchiya, H Naoe, H Igarashi, I Matsuda.   

Abstract

We report here our findings in two Japanese siblings who experienced recurrent bacterial and viral infections since early infancy. Recent symptoms included diarrhoea, conjunctivitis, rashes, headache, sore throat, joint pain, vomiting and vertigo, all similar to those seen in toxic shock syndrome, except for shock. These symptoms improved following gammaglobulin treatment. Staphylococcus aureus with coagulase type IV was continuously isolated from nasal smears producing toxic shock syndrome toxin-1 (TSST-1). Serum antibodies did not or only poorly responded to TSST-1, diphtheria toxoid, varicella virus and rubella virus, whereas total and subclass levels of serum immunoglobulin and in vitro DNA synthesis of lymphocytes stimulated by TSST-1, Staph. aureus, varicella vaccine and mitogens were normal. In the family, ten other members in three generations (five males: five females) including the mother had similar clinical symptoms. Thus, the disease may be inherited in an autosomal dominant fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033920     DOI: 10.1007/bf01956412

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  [Antibody deficiency syndrome; agammaglobulinemia].

Authors:  S BARANDUN; H BUCHLER; A HASSIG
Journal:  Schweiz Med Wochenschr       Date:  1956-01-14

2.  Impaired immune response to polysaccharides.

Authors: 
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

3.  Subtyping lymphocytes in peripheral blood by immunoperoxidase labeling and light scatter/absorption flow cytometry.

Authors:  Y R Kim; G Martin; L Paseltiner; H Ansley; L Ornstein; R J Kanter
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

4.  Antibody deficiency with normal immunoglobulins.

Authors:  C Rothbach; J Nagel; B Rabin; P Fireman
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

5.  Primary immunodeficiency diseases. Report prepared for the WHO by a scientific group on immunodeficiency.

Authors: 
Journal:  Clin Immunol Immunopathol       Date:  1983-09

6.  In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins.

Authors:  A Saxon; R H Kobayashi; R H Stevens; A D Singer; E R Stiehm; S C Siegel
Journal:  Clin Immunol Immunopathol       Date:  1980-10

7.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 8.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

9.  Selective immunodeficiency affecting staphylococcal response.

Authors:  M Monteil; J Hobbs; K Citron
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

10.  Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.

Authors:  D T Umetsu; D M Ambrosino; I Quinti; G R Siber; R S Geha
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

View more
  2 in total

Review 1.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.

Authors:  Rita Kansal; Catherine Davis; Melanie Hansmann; Jon Seymour; Jeffrey Parsonnet; Paul Modern; Steve Gilbert; Malak Kotb
Journal:  J Clin Immunol       Date:  2007-03-06       Impact factor: 8.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.